Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Allergic Conjunctivitis Market: By Drug Class, By Disease Type, By Distribution Channel, and By Region Forecast 2019-2030
Allergic Conjunctivitis Market: By Drug Class, By Disease Type, By Distribution Channel, and By Region Forecast 2019-2030
Allergic Conjunctivitis Market size was valued at US$ 2,443.9 million in 2023 and is anticipated to grow at a CAGR of 6.1% from 2024-2030. Market refers to the pharmaceutical and healthcare industry's segment that deals with the diagnosis, treatment, and management of allergic conjunctivitis. Allergic conjunctivitis is a common eye condition caused by allergies, resulting in inflammation of the conjunctiva (the thin layer of tissue that covers the front of the eye and lines the inside of the eyelids). It can be triggered by various allergens, such as pollen, pet dander, dust mites, or mold spores. The market includes medications, eye drops, and therapies aimed at relieving the symptoms of allergic conjunctivitis, such as itching, redness, tearing, and swelling of the eyes.
Some of the commonly used treatment options include antihistamine eye drops, mast cell stabilizers, nonsteroidal anti-inflammatory drugs (NSAIDs), and corticosteroid eye drops. Increased prevalence, rising awareness, and advancements in treatment options for allergic conjunctivitis are projected to create lucrative opportunities for the market. For instance, according to the Centers for Disease Control and Prevention, allergic conjunctivitis affects an estimated 20% of the general population in the United States.
However, restraints like Limited therapeutic innovations and potential competition from alternative treatments hinder the market. Moreover, the introduction of newer drug products by many market players may aim to influence significant research and development in the market. For instance, Eyevance Pharmaceutical launched Zerviate (cetirizine ophthalmic solution 0.24%) for the treatment of ocular itching associated with allergic conjunctivitis. Service is supplied as a solution for topical administration.
Study Period
2024-2030Base Year
2023CAGR
6.1%Largest Market
EuropeFastest Growing Market
Asia pacific
Allergic conjunctivitis is influenced by several market dynamics on a global scale. The market is driven by the increasing prevalence of allergic disorders and environmental factors that contribute to allergen exposure. Advancements in diagnostic technologies and treatment options, including antihistamines, mast cell stabilizers, and corticosteroids, also foster market growth. Rising awareness about eye health and improved access to healthcare services further contribute to the expansion of the market.
However, certain restraints like limited therapeutic innovations and potential competition from alternative treatments pose challenges. Additionally, economic factors, regulatory requirements, and regional disparities in healthcare infrastructure may impact market dynamics. Despite these challenges, the allergic conjunctivitis market is expected to continue growing due to the ongoing focus on research and development and the increasing demand for effective treatment options.
The allergic conjunctivitis market in the USA and Europe exhibits distinct region-specific characteristics. In the USA, the market is driven by a high prevalence of allergic disorders, increasing environmental allergen exposure, and a robust healthcare system. For instance, according to epidemiological studies, an estimated that the prevalence of ocular allergy in Mexico was approximately 16.7%. The presence of well-established pharmaceutical companies and advanced research facilities fosters continuous product development and innovation.
In Europe, the market experiences growth due to the rising awareness of eye health and allergic conditions, along with favourable government initiatives promoting healthcare access. Different regions in Europe may have varying prevalence rates, influenced by environmental and lifestyle factors. Additionally, the region's stringent regulatory environment may impact product approvals and commercialization timelines. Both regions witness competitive landscapes with key market players competing to gain a significant market share. Collaborations, strategic partnerships, and product launches are common strategies employed by companies in the USA and Europe to expand their market presence.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 2,443.9 million |
|
Market CAGR |
6.1% |
|
By Drug Class |
|
|
By Disease Type |
|
|
By Distribution Channel |
|
Download Free Sample Report
The allergic conjunctivitis market was valued at US$ 2,443.9 million in 2023 and is set to grow at a significant CAGR of 6.1% from 2024-2030
Key opportunities for the market include advancements in treatment options, increased focus on research and development, raising awareness, and potential expansion into an untapped market.
Key trends in the market include the adoption of novel therapies, personalized medicine approaches, digital health solutions for remote monitoring, and a focus on patient-centric care
Novartis AG, Santen Pharmaceuticals, Bausch & Lomb Pharmaceuticals, Alcon, Eyevance Pharmaceuticals, Sun Pharmaceuticals, and Ocular Therapeutics, Inc. are prominent companies operating in the field of allergic conjunctivitis and eye care.
| 1. Executive Summary |
| 2. Global Allergic Conjunctivitis Market Introduction |
| 2.1.Global Allergic Conjunctivitis Market - Taxonomy |
| 2.2.Global Allergic Conjunctivitis Market - Definitions |
| 2.2.1.Drug Class |
| 2.2.2.Disease Type |
| 2.2.3.Distribution Channel |
| 2.2.4.Region |
| 3. Global Allergic Conjunctivitis Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Allergic Conjunctivitis Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Allergic Conjunctivitis Market By Drug Class, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Antihistamines |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Mast Cell Stabilizers |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Corticosteroids |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. others |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Allergic Conjunctivitis Market By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Mild |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Severe |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Allergic Conjunctivitis Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospital pharmacies |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Drug stores |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Retail pharmacies |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Online pharmacies |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Allergic Conjunctivitis Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Allergic Conjunctivitis Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Antihistamines |
| 9.1.2.Mast Cell Stabilizers |
| 9.1.3.Corticosteroids |
| 9.1.4.others |
| 9.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Mild |
| 9.2.2.Severe |
| 9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospital pharmacies |
| 9.3.2.Drug stores |
| 9.3.3. Retail pharmacies |
| 9.3.4. Online pharmacies |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Allergic Conjunctivitis Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Antihistamines |
| 10.1.2.Mast Cell Stabilizers |
| 10.1.3.Corticosteroids |
| 10.1.4.others |
| 10.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Mild |
| 10.2.2.Severe |
| 10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospital pharmacies |
| 10.3.2.Drug stores |
| 10.3.3. Retail pharmacies |
| 10.3.4. Online pharmacies |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Allergic Conjunctivitis Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Antihistamines |
| 11.1.2.Mast Cell Stabilizers |
| 11.1.3.Corticosteroids |
| 11.1.4.others |
| 11.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Mild |
| 11.2.2.Severe |
| 11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospital pharmacies |
| 11.3.2.Drug stores |
| 11.3.3. Retail pharmacies |
| 11.3.4. Online pharmacies |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Allergic Conjunctivitis Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Antihistamines |
| 12.1.2.Mast Cell Stabilizers |
| 12.1.3.Corticosteroids |
| 12.1.4.others |
| 12.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Mild |
| 12.2.2.Severe |
| 12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospital pharmacies |
| 12.3.2.Drug stores |
| 12.3.3. Retail pharmacies |
| 12.3.4. Online pharmacies |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Allergic Conjunctivitis Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Antihistamines |
| 13.1.2.Mast Cell Stabilizers |
| 13.1.3.Corticosteroids |
| 13.1.4.others |
| 13.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Mild |
| 13.2.2.Severe |
| 13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospital pharmacies |
| 13.3.2.Drug stores |
| 13.3.3. Retail pharmacies |
| 13.3.4. Online pharmacies |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Novartis AG |
| 14.2.2. Santen Pharmaceuticals |
| 14.2.3. Bausch & Lomb pharmaceuticals |
| 14.2.4. Alcon |
| 14.2.5. Eyevance pharmaceuticals |
| 14.2.6. Sun Pharmaceuticals |
| 14.2.7.Ocular Therapeutics, inc. |
| 14.2.8. Eton Pharmaceuticals |
| 14.2.9. Allergan Plc. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.